Evidence map›Paper›PMID 28878772›Full record

ArticleFrontiers in immunology2017

Paul de Vos, Zlatan Mujagic, Bart J de Haan, Roland J Siezen, Peter A Bron, Marjolein Meijerink, Jerry M Wells, Ad A M Masclee, Mark V Boekschoten, Marijke M Faas and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Meta-Analysis: Randomized Trials ofFrontiers in immunology · 2021
    Pooled it
  2. Pooled it
  3. Oral intake ofNutrients · 2023
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. The Benefits and Applications ofIranian journal of public health · 2024
    Review
  14. Article
  15. Review
  16. Topical Administration ofMicroorganisms · 2023
    Article
  17. Review
  18. Article
  19. Review
  20. Comparison of the Immunogenic Properties ofFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Paul de VosTop Institute Food and Nutrition, Wageningen, Netherlands.
Zlatan MujagicTop Institute Food and Nutrition, Wageningen, Netherlands.
Bart J de HaanDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Roland J SiezenTop Institute Food and Nutrition, Wageningen, Netherlands.
Peter A BronTop Institute Food and Nutrition, Wageningen, Netherlands.
Marjolein MeijerinkTop Institute Food and Nutrition, Wageningen, Netherlands.
Jerry M WellsTop Institute Food and Nutrition, Wageningen, Netherlands.
Ad A M MascleeDivision of Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM School for Nutrition, and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, Netherlands.
Mark V BoekschotenTop Institute Food and Nutrition, Wageningen, Netherlands.
Marijke M FaasDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Freddy J TroostTop Institute Food and Nutrition, Wageningen, Netherlands.
TiFN · NLMaastricht University · NLUniversity Medical Center Groningen · NLWageningen University & Research · NLRadboud University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orally ingested bacteria interact with intestinal mucosa and may impact immunity. However, insights in mechanisms involved are limited. In this randomized placebo-controlled cross-over trial, healthy human subjects were given

Indexed as

adaptive immunityindomethacinintestinal mucosal immunityLactobacillus plantarumnon-steroidal anti-inflammatory drugprobiotics

Identifiers

PMID28878772
PMCPMC5572349
OpenAlexW2747851425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.